Targeting the Interaction between the SH3 Domain of Grb2 and Gab2
Authors:
- Francesca MalagrinòFMFrancesca Malagrinò
- Antonio ColucciaAntonio Coluccia
- Marianna BufanoMBMarianna Bufano
- Giuseppe La ReginaGRGiuseppe La Regina
- Michela PuxedduMPMichela Puxeddu
- Angelo TotoAngelo Toto
- Lorenzo ViscontiLVLorenzo Visconti
- Alessio PaoneAlessio Paone
- Maria Chiara MagnificoMMMaria Chiara Magnifico
- Francesca TroiloFTFrancesca Troilo
- Francesca CutruzzolàFCFrancesca Cutruzzolà
- Romano SilvestriRSRomano Silvestri
Open Access
Abstract
Gab2 is a scaffolding protein, overexpressed in many types of cancers, that plays a key role in the formation of signaling complexes involved in cellular proliferation, migration, and differentiation. The interaction between Gab2 and the C-terminal SH3 domain of the protein Grb2 is crucial for the activation of the proliferation-signaling pathway Ras/Erk, thus representing a potential pharmacological target. In this study, we identified, by virtual screening, seven potential inhibitor molecules that were experimentally tested through kinetic and equilibrium binding experiments. One compound showed a remarkable effect in lowering the affinity of the C-SH3 domain for Gab2. This inhibitory effect was subsequently validated in cellula by using lung cancer cell lines A549 and H1299. Our results are discussed under the light of previous works on the C-SH3:Gab2 interaction.Keywords
This publication has 23 references indexed in Scilit:
- Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1Blood, 2016
- GAB2—a Scaffolding Protein in CancerMolecular Cancer Research, 2012
- Order and disorder in large multi-site docking proteins of the Gab family—implications for signalling complex formation and inhibitor design strategiesMolecular BioSystems, 2011
- Overexpression of Grb2-associated Binder 2 in Human Lung CancerInternational Journal of Biological Sciences, 2011
- Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomasPathology, 2007
- GAB2 is a novel target of 11q amplification in AML/MDSGenes, Chromosomes and Cancer, 2006
- A role for the scaffolding adapter GAB2 in breast cancerNature Medicine, 2005
- Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutationsCancer Cell, 2005
- Requirement of Gab2 for mast cell development and KitL/c-Kit signalingBlood, 2002
- Gab2, a New Pleckstrin Homology Domain-containing Adapter Protein, Acts to Uncouple Signaling from ERK Kinase to Elk-1Journal of Biological Chemistry, 1999